Skip to main content

Table 1 Values of antioxidant capacity of lipid- (ACL) and water-soluble (ACW) antioxidants in dogs diagnosed with myxomatous mitral valve degeneration and anaesthetised with propofol and sevoflurane (MMVD/PS) or propofol (MMVD/P) and in control dogs anaesthetised with propofol and sevoflurane (PS)

From: Antioxidant capacity of lipid- and water-soluble antioxidants in dogs with subclinical myxomatous mitral valve degeneration anaesthetised with propofol or sevoflurane

Variable

Group

Basal

5 min

60 min

6 h

ACL [nmol/L]

MMVD/PS

133.9 ± 31.3

130.9 ± 29.9

134.3 ± 31.9

131.8 ± 26.2

PS

87.6 ± 12.2a

86.6 ± 13.7a

93.0 ± 18.6a

84.9 ± 22.2a

MMVD/P

116.4 ± 22.9

118.2 ± 19.9

134.0 ± 23.3*

119.1 ± 24.6

ACW [nmol/L]

MMVD/PS

35.1 ± 8.9

47.1 ± 15.6

52.8 ± 17.2*

42.1 ± 15.5

PS

29.6 ± 9.6

37.4 ± 4.8

44.3 ± 8.2*

35.44 ± 8.0

MMVD/P

26.5 ± 9.6

42.5 ± 14.2*

79.2 ± 22.0* a

55.8 ± 30.6*

  1. Data are presented as (mean ± SD). Abbreviations: basal, basal values; 5 min, 5 min after induction to anaesthesia; 60 min, 60 min after induction to anaesthesia; 6 h, 6 h after induction to anaesthesia. * p < 0.05 compared to basal values; a p < 0.05 compared to MMVD/PS
Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us